+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medium & Long Chain Fat Emulsion Injection(C8~24Ve) Market - Global Forecast 2025-2030- Product Image
Medium & Long Chain Fat Emulsion Injection(C8~24Ve) Market - Global Forecast 2025-2030- Product Image
Sale

Medium & Long Chain Fat Emulsion Injection(C8~24Ve) Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6133810
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The medium and long chain fat emulsion market is undergoing rapid transformation, driven by advances in lipid metabolism research, superior formulation technologies, and growing patient demographics requiring personalized intravenous nutrition. This momentum is fostering both product innovation and a fundamentally new approach to clinical nutrition delivery across healthcare settings.

Market Snapshot: Medium and Long Chain Fat Emulsion

The global landscape for medium and long chain fat emulsions is defined by an intersection of clinical demand, ongoing R&D, and evolving supply chain strategies. Growing incidence of chronic diseases and the aging population are pushing healthcare systems toward advanced lipid emulsions that support tailored nutritional needs. Enhanced emulsion stability, improved delivery mechanisms, and regulatory engagement are enabling providers to optimize clinical outcomes, while procurement teams face new complexities such as changing trade tariffs and regional sourcing requirements. Segment differentiation by product type, application, and distribution channel remains central to market expansion, catalyzed further by investment in collaborative research and digital health integration.

Scope & Segmentation

This report offers comprehensive market intelligence across the entire value chain of medium and long chain fat emulsions:

  • Product Types: Long chain emulsions, medium chain emulsions, and blended medium and long chain emulsions, each delivering unique physiological benefits for diverse patient needs.
  • Applications: Includes clinical nutrition and parenteral nutrition, supporting both acute care in hospitals and longer-term requirements in home-based care settings.
  • End Users: Covers clinics (outpatient and specialty), home care (professional assisted, self-administered), and hospitals (private and public) to address settings with varied operational priorities.
  • Distribution Channels: Considers hospital pharmacies (inpatient and outpatient), online stores (e-commerce, manufacturer websites), and retail pharmacies (chain and independent) for access and patient counseling needs.
  • Regions: Analysis spans Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with representation from major EU economies, GCC, and emerging markets), and Asia-Pacific (China, India, Japan, Australia, and others) reflecting both market maturity and supply chain localization.
  • Technology Innovations: Emphasizes advances in nanoparticle stabilization, emulsifier design, digital infusion monitoring, and remote adherence solutions that improve biocompatibility, safety, and therapy management.

Key Takeaways for Decision-Makers

  • Recent advances in lipid science have enabled precise product differentiation, allowing for optimized clinical protocols tailored to patient-specific metabolic profiles.
  • Technological integration, including AI-driven stability modeling and digital infusion tracking, is streamlining delivery practices and supporting more robust patient safety initiatives.
  • Home care and outpatient settings are emerging as critical growth drivers, reflecting a shift toward patient autonomy and continuity of care outside traditional hospitals.
  • Cross-functional partnerships between clinical nutritionists, pharmacists, and digital health companies are driving both innovation and operational efficiency.
  • Manufacturers with diversified sourcing strategies and contractual flexibility are better positioned to navigate regulatory and supply chain disruptions.
  • Global regulatory environments demonstrate significant variation, necessitating region-specific entry and compliance strategies for stakeholder success.

Tariff Impact: Navigating US Trade Adjustments

Starting in 2025, adjusted US trade tariffs on imported triglyceride sources and production equipment will add complexity to procurement, supplier negotiations, and cost management. Businesses are countering by diversifying raw material origins, negotiating adaptive contracts, and increasing inventory buffers to handle price volatility and logistical delays. These measures will be decisive for maintaining supply continuity and budget discipline as healthcare providers realign formulary choices and prioritize operational agility.

Methodology & Data Sources

This report is underpinned by a mixed-methods approach, integrating structured interviews with industry stakeholders, review of peer-reviewed journals, regulatory filings, and patent analyses. Data triangulation and iterative expert validation sessions ensure the accuracy and robustness of insights, with scenario analysis applied to capture impacts of demographic, technological, and policy shifts.

Why This Report Matters

  • Guides executive teams through evolving clinical and commercial landscapes for medium and long chain fat emulsions, supporting strategic decision-making.
  • Delivers actionable insights on supply chain, innovation, and regulatory trends—crucial for product portfolio planning and regional market entry.
  • Helps procurement leaders minimize risk while optimizing formulation selection and contract structures in light of emerging trade policies.

Conclusion

The medium and long chain fat emulsion market is defined by scientific advancement, cross-sector collaboration, and shifting procurement landscapes. Stakeholders prepared to act on these insights will be positioned to deliver differentiated patient value and sustainable growth.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for omega-3 enriched medium and long chain fat emulsion injections in critical care settings
5.2. FDA guidance updates fueling reformulation of C8-C24 intravenous lipid emulsions for improved safety profiles
5.3. Growth of home parenteral nutrition programs driving innovation in stable long chain fat emulsion formulations
5.4. Competitive pricing pressure from biosimilar fat emulsions prompting strategic partnerships among key players
5.5. Advancements in nanoemulsion technologies enhancing bioavailability of medium and long chain triglycerides
5.6. Emergence of ready-to-use premixed fat emulsion bags reducing compounding errors in hospital pharmacies
5.7. Expansion of fat emulsion injection usage in pediatric intensive care units to address malnutrition challenges
5.8. Sustainability initiatives leading manufacturers to source certified sustainable medium and long chain oils
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Medium & Long Chain Fat Emulsion Injection(C8~24Ve) Market, by Product Type
8.1. Introduction
8.2. Long Chain
8.3. Medium Chain
8.4. Mixed Medium And Long Chain
9. Medium & Long Chain Fat Emulsion Injection(C8~24Ve) Market, by Application
9.1. Introduction
9.2. Clinical Nutrition
9.3. Parenteral Nutrition
10. Medium & Long Chain Fat Emulsion Injection(C8~24Ve) Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Outpatient Clinic
10.2.2. Specialty Clinic
10.3. Home Care
10.3.1. Professional Assisted
10.3.2. Self Administered
10.4. Hospitals
10.4.1. Private Hospital
10.4.2. Public Hospital
11. Medium & Long Chain Fat Emulsion Injection(C8~24Ve) Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.2.1. Inpatient Pharmacy
11.2.2. Outpatient Pharmacy
11.3. Online Store
11.3.1. E Commerce Platform
11.3.2. Manufacturer Website
11.4. Retail Pharmacy
11.4.1. Chain Pharmacy
11.4.2. Independent Pharmacy
12. Americas Medium & Long Chain Fat Emulsion Injection(C8~24Ve) Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Medium & Long Chain Fat Emulsion Injection(C8~24Ve) Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Medium & Long Chain Fat Emulsion Injection(C8~24Ve) Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. B. Braun Melsungen AG
15.3.2. Fresenius Kabi AG
15.3.3. Baxter International Inc.
15.3.4. Nestlé Health Science S.A.
15.3.5. Par Pharmaceutical Companies, Inc.
15.3.6. CordenPharma International GmbH
15.3.7. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
15.3.8. Sichuan Kelun Pharmaceutical Co., Ltd.
15.3.9. Livzon Pharmaceutical Group Inc.
15.3.10. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET: RESEARCHAI
FIGURE 24. MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET: RESEARCHSTATISTICS
FIGURE 25. MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET: RESEARCHCONTACTS
FIGURE 26. MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY LONG CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY LONG CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY MEDIUM CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY MEDIUM CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY MIXED MEDIUM AND LONG CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY MIXED MEDIUM AND LONG CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICAL NUTRITION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PROFESSIONAL ASSISTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PROFESSIONAL ASSISTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY E COMMERCE PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY E COMMERCE PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 126. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 127. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 128. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 129. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 130. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 131. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2018-2024 (USD MILLION)
TABLE 136. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2025-2030 (USD MILLION)
TABLE 137. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 138. CANADA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 139. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 146. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 147. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. MEXICO MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY ONLINE STORE, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 248. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 249. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. GERMANY MEDIUM & LONG CHAIN FAT EMULSION INJECTION(C8~24VE) MARKET SIZE, BY DISTRIBUTION CHANNEL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Medium & Long Chain Fat Emulsion Injection（C8～24Ve） market report include:
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Nestlé Health Science S.A.
  • Par Pharmaceutical Companies, Inc.
  • CordenPharma International GmbH
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Livzon Pharmaceutical Group Inc.
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

Related Topics

Related Reports

Structured Fat Emulsion Injection Market - Global Forecast 2025-2030 - Product Image

Structured Fat Emulsion Injection Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Brucea Javanica Oil Emulsion Injection Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Brucea Javanica Oil Emulsion Injection Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Hydroxyapatite Microsphere Filler for Injection Market - Global Forecast 2025-2030 - Product Image

Hydroxyapatite Microsphere Filler for Injection Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Deoxycholic Acid Injection Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Deoxycholic Acid Injection Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Injection Pen Market Report 2025 - Product Image

Injection Pen Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.